Bid guide
How to bid on Advanced Dermal Regeneration Substitutes for Severe Burns (BARDA)
What BARDA is buying and why it matters
The Biomedical Advanced Research and Development Authority (BARDA) is looking for information on advanced dermal regeneration substitutes. These technologies should help treat severe burns and complex traumatic injuries, especially in mass casualty situations.
BARDA is interested in solutions that can address large-area skin loss. This includes technologies that support temporary wound healing, faster wound closure, infection control, and functional tissue regeneration. This is a Request for Information (RFI) to understand available technologies, not a direct contract opportunity.
Key dates and what happens at the deadline
This RFI was published on July 28, 2026. The deadline for submitting information is August 28, 2026, at 4:00 PM ET.
At the deadline, BARDA will stop accepting submissions. This RFI is for market research purposes only; no awards will be made from this solicitation.
Who this opportunity suits
This opportunity is suitable for firms in the healthcare sector, specifically those involved in medical countermeasure technologies, advanced wound care, and regenerative medicine. Companies with commercially available or near-commercial availability technologies for skin substitutes and related treatments for severe burns and traumatic injuries should consider responding.
This RFI is for companies that can provide solutions for large-area skin loss, focusing on temporary healing, accelerated closure, infection control, and tissue regeneration.
How to respond
To access the full details of this RFI, click “View original source” to open the opportunity on the portal. If the first click takes you to the portal’s homepage, click the link again to go directly to the bid.
You may need a free account to view all documents, though some bids allow viewing without one. Follow the instructions provided within the RFI document for submitting your information.
Practical tips for preparing a competitive response
When responding to an RFI, focus on providing clear, concise, and comprehensive information about your technology. Highlight how your solution directly addresses BARDA's stated needs, such as large-area skin loss, temporary healing, accelerated closure, infection control, and functional tissue regeneration.
Emphasize the current development stage of your technology, especially if it is commercially available or near-commercial. Provide data or evidence to support your claims regarding efficacy and readiness. Even though this is not a contract, a well-prepared response can position your company for future opportunities with BARDA.
See the live bid — deadline, agency details, and how to respond
Dates and requirements can change via addenda; always verify on the bid page and at the original source before responding.
View this bid on BiddingSimpleThis guide was prepared by BiddingSimple from the solicitation’s public posting. It is not official guidance from Biomedical Advanced Research and Development Authority (BARDA); the original posting controls.